S32

Activity from announced rounds

Activity in this selectionOct 17, 2026 · Jul 20, 2026

S32, formerly identified as Section 32, is a venture firm whose stated focus includes AI, computational biology, physical AI, infrastructure, cybersecurity and enterprise technology.

Recorded funding activity

The RoundOS history includes Basecamp’s biological models, Snorkel’s training-data systems, Ema’s enterprise agents and Network Bio’s tissue-data models. These are covered financing announcements rather than a complete portfolio.

Sources
Rounds participated in
7
Confirmed lead rounds
3
1 roles undisclosed
New companies
7
First participation on record · 0 follow-on
Funding in participating rounds
$719.3M
7 disclosed · full round size, not this investor’s share

By stage

Series B2
Series C+2
Undisclosed2
Seed1

By primary sector

AI4
Biotech2
Healthtech1

By country

United States6
United Kingdom1

Rounds

7 in this selection
Ema

Ema builds AI Employees that automate multi-step work across enterprise HR, IT and finance systems. Businesses use its agents for processes such as recruiting, onboarding, benefits, IT support, invoice handling and payroll; the platform connects to existing applications and includes tools for configuring, governing and improving workflows.

$77MSeries B
Participant
Basecamp Research

Basecamp Research builds biological AI models from genomic data to help design therapeutics, including protein-based medicines.

$140MSeries C
Lead
Snorkel AI

Snorkel AI helps enterprises build expert-curated training data and benchmarks for advanced AI models and agents.

$350MSeries E
Lead
empirik.ai

empirik gives engineering teams an AI agent and live graph of their cloud, on-premises and SaaS estate to assess infrastructure changes before execution. It connects a proposed change to affected resources and services, calculates its blast radius, and routes a plan through approval, execution and verification workflows.

$21MFunding
Participant
SciFin

SciFin gives enterprise revenue teams a continuously updated view of accounts, deals, forecasts, territories and customer conversations. Its AI companion, Pixie, uses that connected context to answer business questions, identify risks, prepare reports and recommend follow-up actions.

$44MSeed
Participant
Faro AI

Structured data and AI agents for clinical development and pharmaceutical trial operations.

$37.3MSeries B
Lead
Network Bio

Builds AI models trained on patient tissue and clinical data for disease diagnostics

$50MStrategic
Role not disclosed